- Biocon Limited has successfully completed the purchase of 1,97,99,305 equity shares of its subsidiary, Biocon Biologics Limited (BBL).
- The acquisition was approved by the Board of Dir…
Join the vibrant privacy-ensured Dzambhala community on
Want to give feedback on this story? Write to us at [email protected]